SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-14-003519
Filing Date
2014-09-09
Accepted
2014-09-09 16:26:34
Documents
10
Period of Report
2014-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pphm_10q-073114.htm 10-Q 504063
2 CERTIFICATION pphm_10q-ex3101.htm EX-31.1 7565
3 CERTIFICATION pphm_10q-ex3102.htm EX-31.2 7794
4 CERTIFICATION pphm_10q-ex3200.htm EX-32 6276
  Complete submission text file 0001019687-14-003519.txt   2674702

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pphm-20140731.xml EX-101.INS 287430
6 XBRL SCHEMA FILE pphm-20140731.xsd EX-101.SCH 24321
7 XBRL CALCULATION FILE pphm-20140731_cal.xml EX-101.CAL 44382
8 XBRL DEFINITION FILE pphm-20140731_def.xml EX-101.DEF 37639
9 XBRL LABEL FILE pphm-20140731_lab.xml EX-101.LAB 203046
10 XBRL PRESENTATION FILE pphm-20140731_pre.xml EX-101.PRE 137913
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-32839 | Film No.: 141093606
SIC: 2834 Pharmaceutical Preparations